The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 5,529 | 955,000 | SH | DFND | 1,2 | 0 | 955,000 | 0 | |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 16,043 | 1,019,282 | SH | DFND | 1,2 | 0 | 1,019,282 | 0 | |
ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | 12,036 | 1,200,000 | SH | DFND | 1,2 | 0 | 1,200,000 | 0 | |
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 1,315 | 2,500,000 | SH | DFND | 1,2 | 0 | 2,500,000 | 0 | |
ALKERMES PLC | SHS | G01767105 | 11,332 | 507,500 | SH | DFND | 1,2 | 0 | 507,500 | 0 | |
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 24,829 | 3,448,521 | SH | DFND | 1,2 | 0 | 3,448,521 | 0 | |
BRIDGEBIO PHARMA INC | COM | 10806X102 | 10,437 | 1,050,000 | SH | DFND | 1,2 | 0 | 1,050,000 | 0 | |
CINCOR PHARMA INC | COM | 17240Y109 | 9,889 | 301,324 | SH | DFND | 1,2 | 0 | 301,324 | 0 | |
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 2,798 | 799,439 | SH | DFND | 1,2 | 0 | 799,439 | 0 | |
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 1,415 | 70,621 | SH | DFND | 1,2 | 0 | 70,621 | 0 | |
GALAPAGOS NV | SPON ADR | 36315X101 | 13,065 | 306,411 | SH | DFND | 1,2 | 0 | 306,411 | 0 | |
GENERATION BIO CO | COM | 37148K100 | 4,381 | 825,077 | SH | DFND | 1,2 | 0 | 825,077 | 0 | |
GRACELL BIOTECHNOLOGIES INC | SPONSORED ADS | 38406L103 | 1,446 | 449,049 | SH | DFND | 1,2 | 0 | 449,049 | 0 | |
HERON THERAPEUTICS INC | COM | 427746102 | 23,484 | 5,645,161 | SH | DFND | 1,2 | 0 | 5,645,161 | 0 | |
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 3,686 | 78,527 | SH | DFND | 1,2 | 0 | 78,527 | 0 | |
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 1,465 | 105,000 | SH | DFND | 1,2 | 0 | 105,000 | 0 | |
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 28,657 | 215,000 | SH | DFND | 1,2 | 0 | 215,000 | 0 | |
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 22,515 | 1,551,719 | SH | DFND | 1,2 | 0 | 1,551,719 | 0 | |
LARIMAR THERAPEUTICS INC | COM | 517125100 | 3,632 | 1,135,000 | SH | DFND | 1,2 | 0 | 1,135,000 | 0 | |
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 6,207 | 95,500 | SH | DFND | 1,2 | 0 | 95,500 | 0 | |
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 1,437 | 1,019,091 | SH | DFND | 1,2 | 0 | 1,019,091 | 0 | |
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 6,200 | 674,656 | SH | DFND | 1,2 | 0 | 674,656 | 0 | |
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 3,818 | 492,000 | SH | DFND | 1,2 | 0 | 492,000 | 0 | |
NEKTAR THERAPEUTICS | COM | 640268108 | 1,433 | 447,820 | SH | DFND | 1,2 | 0 | 447,820 | 0 | |
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 4,137 | 316,256 | SH | DFND | 1,2 | 0 | 316,256 | 0 | |
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 2,260 | 1,965,449 | SH | DFND | 1,2 | 0 | 1,965,449 | 0 | |
PLIANT THERAPEUTICS INC | COM | 729139105 | 21,762 | 1,041,737 | SH | DFND | 1,2 | 0 | 1,041,737 | 0 | |
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 27,526 | 3,560,984 | SH | DFND | 1,2 | 0 | 3,560,984 | 0 | |
PRECISION BIOSCIENCES INC | COM | 74019P108 | 3,524 | 2,710,805 | SH | DFND | 1,2 | 0 | 2,710,805 | 0 | |
RAPT THERAPEUTICS INC | COM | 75382E109 | 7,579 | 315,000 | SH | DFND | 1,2 | 0 | 315,000 | 0 | |
RELMADA THERAPEUTICS INC | COM | 75955J402 | 18,880 | 510,000 | SH | DFND | 1,2 | 0 | 510,000 | 0 | |
REPLIMUNE GROUP INC | COM | 76029N106 | 6,735 | 390,000 | SH | DFND | 1,2 | 0 | 390,000 | 0 | |
SEAGEN INC | COM | 81181C104 | 10,467 | 76,500 | SH | DFND | 1,2 | 0 | 76,500 | 0 | |
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 692 | 68,915 | SH | DFND | 1,2 | 0 | 68,915 | 0 | |
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 23,805 | 966,108 | SH | DFND | 1,2 | 0 | 966,108 | 0 | |
TRICIDA INC | COM | 89610F101 | 9,118 | 870,000 | SH | DFND | 1,2 | 0 | 870,000 | 0 | |
UROGEN PHARMA LTD | COM | M96088105 | 7,267 | 873,424 | SH | DFND | 1,2 | 0 | 873,424 | 0 | |
VAXCYTE INC | COM | 92243G108 | 14,400 | 600,000 | SH | DFND | 1,2 | 0 | 600,000 | 0 | |
VENTYX BIOSCIENCES INC | COM | 92332V107 | 9,425 | 269,967 | SH | DFND | 1,2 | 0 | 269,967 | 0 | |
XENON PHARMACEUTICALS INC | COM | 98420N105 | 30,685 | 850,000 | SH | DFND | 1,2 | 0 | 850,000 | 0 |